Vuori Kristiina MD 4
4 · Inhibrx, Inc. · Filed May 26, 2022
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Vuori Kristiina MD
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-25+15,000→ 45,000 totalExercise: $12.57Exp: 2032-05-25→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on May 25, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.